Calliditas Therapeutics Stock Forecast - Market Facilitation Index
| CALT Stock | USD 20.33 0.23 1.12% |
Calliditas Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Calliditas Therapeutics stock prices and determine the direction of Calliditas Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Calliditas Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Calliditas Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Calliditas Therapeutics' systematic risk associated with finding meaningful patterns of Calliditas Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Calliditas Therapeutics to cross-verify your projections. Calliditas |
Open Interest Against 2024-05-17 Calliditas Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Calliditas Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Calliditas Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Calliditas Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Calliditas Therapeutics' open interest, investors have to compare it to Calliditas Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Calliditas Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Calliditas. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Calliditas Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Calliditas Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Calliditas Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Market Facilitation Index is simply a difference between period high and low prices divided by period trading volume.| Previous Market Facilitation Index | Market Facilitation Index | Trend |
| 4.0E-4 | 2.0E-4 |
| Check Calliditas Therapeutics Volatility | Backtest Calliditas Therapeutics | Information Ratio |
Calliditas Therapeutics Trading Date Momentum
| On May 09 2024 Calliditas Therapeutics was traded for 20.33 at the closing time. The top price for the day was 20.33 and the lowest listed price was 19.77 . The trading volume for the day was 2.3 K. The trading history from May 9, 2024 did not affect price variability. The overall trading delta against the current closing price is 2.75% . |
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
| Compare Calliditas Therapeutics to competition |
Other Forecasting Options for Calliditas Therapeutics
For every potential investor in Calliditas, whether a beginner or expert, Calliditas Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Calliditas Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Calliditas. Basic forecasting techniques help filter out the noise by identifying Calliditas Therapeutics' price trends.View Calliditas Therapeutics Related Equities
| Risk & Return | Correlation |
Calliditas Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Calliditas Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Calliditas Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Calliditas Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Calliditas Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Calliditas Therapeutics shares will generate the highest return on investment. By undertsting and applying Calliditas Therapeutics stock market strength indicators, traders can identify Calliditas Therapeutics entry and exit signals to maximize returns.
Calliditas Therapeutics Risk Indicators
The analysis of Calliditas Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Calliditas Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting calliditas stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.61 | |||
| Standard Deviation | 3.39 | |||
| Variance | 11.52 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Calliditas Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Calliditas Therapeutics' short interest history, or implied volatility extrapolated from Calliditas Therapeutics options trading.
Pair Trading with Calliditas Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Calliditas Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calliditas Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Calliditas Stock
| 0.64 | VRAX | Virax Biolabs Group Fiscal Year End 12th of June 2024 | PairCorr |
Moving against Calliditas Stock
| 0.63 | ACRV | Acrivon Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.57 | RVMD | Revolution Medicines Financial Report 13th of May 2024 | PairCorr |
| 0.56 | PULM | Pulmatrix | PairCorr |
| 0.41 | ELYM | Eliem Therapeutics | PairCorr |
The ability to find closely correlated positions to Calliditas Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Calliditas Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Calliditas Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Calliditas Therapeutics to buy it.
The correlation of Calliditas Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Calliditas Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Calliditas Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Calliditas Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Calliditas Therapeutics to cross-verify your projections. For more information on how to buy Calliditas Stock please use our How to Invest in Calliditas Therapeutics guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Calliditas Stock analysis
When running Calliditas Therapeutics' price analysis, check to measure Calliditas Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calliditas Therapeutics is operating at the current time. Most of Calliditas Therapeutics' value examination focuses on studying past and present price action to predict the probability of Calliditas Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calliditas Therapeutics' price. Additionally, you may evaluate how the addition of Calliditas Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Calliditas Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Calliditas Therapeutics. If investors know Calliditas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Calliditas Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.61) | Revenue Per Share 44.972 | Quarterly Revenue Growth 0.052 | Return On Assets (0.13) | Return On Equity (0.85) |
The market value of Calliditas Therapeutics is measured differently than its book value, which is the value of Calliditas that is recorded on the company's balance sheet. Investors also form their own opinion of Calliditas Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Calliditas Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Calliditas Therapeutics' market value can be influenced by many factors that don't directly affect Calliditas Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Calliditas Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Calliditas Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Calliditas Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.